StimLabs, LLC

1225 Northmeadow Parkway
Suite 104
Roswell
Georgia
30076
United States

Tel: 888-346-9802
Fax: 470-719-2085

About StimLabs, LLC

StimLabs, LLC, was founded in 2015 with a desire to advance the state of regenerative medicine. Within a year of its inception, StimLabs built and certified an ISO Class 7 clean room facility, conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property. StimLabs portfolio of products includes Ascent, a shelf-stable injectable amniotic fluid allograft, and Revita®, an intact human placental membrane allograft that preserves all layers of the native tissue in a shelf-stable format. These groundbreaking products apply to a wide range of clinical applications and provide a foundation on which StimLabs is developing new regenerative technologies at the intersection of pharmaceuticals, medical devices, and tissue transplants.
YEAR FOUNDED:
2015
LEADERSHIP:
Founder & CEO: John Daniel
VP, Sales: Bob Milani
VP, Product Development: Sarah Griffiths Langbord PhD
VP, Quality Assurance & Regulatory Affairs: Melissa Gaynor O’Connor
PRODUCTS
Please click here for Stimlabs' products.

9 articles about StimLabs, LLC

Stimlabs(R) LLC Granted Issuance of Two New Patents Further Establishing the Company’s Intellectual Property Position for Advancements in Regenerative Medicine

11/1/2023

Stimlabs LLC, a leader in regenerative medicine, continues to achieve advancements in the development and patenting of innovative, industry-leading technologies and products.
Stimlabs® LLC Announces Launch of Relese® - A Uniquely Fenestrated Allograft for Chronic and Acute Wounds

8/24/2023

Stimlabs LLC, ("StimLabs"), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds.
StimLabs, LLC. Announces Launch of Second Umbilical Cord Derived Product: Corplex™ P

8/27/2020

StimLabs, a leader in regenerative technologies and products that are revolutionizing patient care, today announced the launch of Corplex P, a unique product solution to a common clinical need. Corplex P, a shelf
StimLabs Announces Launch of New Product: Corplex™

1/29/2020

StimLabs, a leader in regenerative technologies and products that are revolutionizing patient care, today announced the launch of Corplex, the first of two umbilical cord derived products launching this year.
StimLabs Announces Enrollment of First Patient in Trial Investigating the Efficacy of Full-Thickness Human Placental Graft Revita® in Diabetic Foot Ulcers

2/1/2019

First patient enrolled in StimLabs Revita Efficacy Trial for Diabetic Foot Ulcers
StimLabs Announces Department of Veterans Affairs (VA) And Department of Defense (DoD) Agreements

12/10/2018

Both Revita and Ascent products are now much more accessible at both the Department of Veterans Affairs (VA) and the Department of Defense (DoD).
StimLabs Announces Enrollment of First Patient in Evaluating Efficacy of Full Thickness Placental Allograft, Revita®, in Lumbar Microdiscectomy Outcomes

6/19/2018

StimLabs announced that the first patient has been enrolled in the company sponsored clinical trial assessing the safety and efficacy of Revita full thickness placental allograft placement following lumbar microdiscectomy procedures.
StimLabs Announces Partnership With American Military Medical Organization

8/1/2017
StimLabs Enters Regenerative Medicine Market With Two Groundbreaking Amniotic Tissue Products

7/26/2017